Share Name Share Symbol Market Type Share ISIN Share Description
Ixico LSE:IXI London Ordinary Share GB00BCLY7L40 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 28.00p 27.00p 29.00p 28.00p 28.00p 28.00p 2,204 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 3.1 -1.4 -7.9 - 7.41

Ixico (IXI) Latest News (1)

More Ixico News
Ixico Takeover Rumours

Ixico (IXI) Share Charts

1 Year Ixico Chart

1 Year Ixico Chart

1 Month Ixico Chart

1 Month Ixico Chart

Intraday Ixico Chart

Intraday Ixico Chart

Ixico (IXI) Discussions and Chat

Ixico Forums and Chat

Date Time Title Posts
22/1/201607:26Ixico PLC74

Add a New Thread

Ixico (IXI) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Ixico trades in real-time

Ixico (IXI) Top Chat Posts

Ixico Daily Update: Ixico is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker IXI. The last closing price for Ixico was 28p.
Ixico has a 4 week average price of 24.65p and a 12 week average price of 28.32p.
The 1 year high share price is 42p while the 1 year low share price is currently 23p.
There are currently 26,473,191 shares in issue and the average daily traded volume is 10,878 shares. The market capitalisation of Ixico is £7,412,493.48.
loobrush: Well not many seem interested in this share at the moment but as a healthcare share and in dementia they should be. Clearly undervalued, I expect that an analyst will pick this up soon, maybe when results out. Directors recently awarded options. The award of options under the Scheme are over the ordinary shares in the Company and are exercisable at an exercise price of 49.0p subject to various conditions. For each Executive Director, half of the options will not vest earlier than one year from the date of grant and will be subject to absolute share price performance. The options will vest in equal tranches on the first, second the third anniversary of grant with an annual hurdle of 10% share price appreciation being required in any 12 month period. The other half of the options are subject to a number of enhanced performance criteria including a more than doubling of the share price in a twelve month period or other corporate and strategic goals being met. So Directors have options which are only exercisable if share price goes up and minimum level to get some is 49p+10% = 54p -that's 35% above today's price. Also some of the options subject to DOUBLING SHARE PRICE That's a big incentive to get the company really moving.
loobrush: lse board Ixico has dropped to a low for the year at 35p and in my view is due for a big bounce. The company is one of two on the market involved in Dementia diagnosis and has recently launched a dimentia diagnostic kit which it is promoting. With the immense focus on this disease by the government this could turn into really big business Directors were recently granted options at 49p with the ability to take these up subject to increasing the share price from 49p. The company has been doing very well lately too. An update is due from the company in December Cash in the bank of over £3 million and company valued at only £5.25 million inc cash this has got to be a steal. Was as high as 120p has dropped a lot.
loobrush: see RNS Prof Hill MD of IXico speaking in China again with UK Minister of oF Health. I don't think he is there just to talk, is another deal in the offing ? await contract news and a share price jump
loobrush: I think you may be wrong in your assumption that its not worth chasing ,as you have pointed out with only a few shares being traded this exagerates the price movement, both up and down. However most investors have not cottoned on to what this company actually does and what the potential is. A visit to the IXICO website explains this in some detail and is very worthwhile, however this does not provide any financial projections of the three areas of their business. I am advised that this will be forthcoming in the new year. However, waiting until this is available or the company is anylised in the press or elsewhere may be unwise as the share price will take off again on any positive comment and you may miss the boat.
loobrush: latest grant award is brilliant news. Cash is rolling in with half the companies value in by cash in hand valuing the whole business at only £9 million To find out more what the company is about look at this info on They are finalising the design of the diagnostic kit to enable it to be used worldwide in conjunction with AstraZeneca and Imperial College plus other unnamed large company. See latest RNS They have global ambitions. Share price wont stay at these levels for long.
loobrush: from coldascheese on iii board "Researching more into and dementia and the other brain problems that there are I have only just understood how really big the problem is and what this will mean for IXICO. According to article in the Daily mail today(10 December) page 51, 25 billion has been spent on research into cures and treatments of DEMENTIA and ALZHEIMER'S and the amount is going to increase dramatically. Tomorrow sees the start of the G8 summit in London on this problem where all the experts from the worlds leading economies will meet to coordinate an action plan for tackling this. Professor Hill the chief exec of IXICO who recently signed the deal with the Chinese Academy of Medical Science will be in attendance. Tonight on NEWSNIGHT this summit meeting and the action required from it was discussed in more detail with the minister responsible advising that a great deal t more money was going to be spent on research into this problem. With Professor Hill and his team at IXICO being the only quoted company in this field and WORLD LEADERS at what the do in research IXICO will receive much greater publicity than of late and show what a truly great opportunity exists with this company and share price. They are already earning money and have over 8 million in the bank so are not like your usual cash hungry research/medical companies on multiple pe ratios valued at ten times the amount. I would also remind all about the company from their recent Aim Listing IXICO brings innovative technologies to those researching, diagnosing and treating serious diseases, especially dementia. Its technologies enable timely decision-making aimed at improving patient outcomes. IXICO was founded with a mission to translate image acquisition, management and analysis technology and know-how, which the founders had developed together, into commercial products. These target the expanding area of imaging to inform decision-making during drug development, especially for treatments for Alzheimer's Disease and other brain disorders. This has resulted in commercially successful products being launched in the clinical trials and experimental medicine markets and such products are now being readied for launch into the wider clinical diagnostic market to support the diagnosis of dementia Products ready for launch it says. Small holding PI's who have not understood the potential here have been selling today I would advise them to do bit more research as the potential of the company and what could come from this summit to the benefit of IXICO will be truly dramatic. The Chinese have recognized it-this share will be many multiples of todays price in a years time. " THIS HAS GOT TO BE AN OUSTANDING BUY AND I AM ADDING TO MY HOLDING
loobrush: I totally agree the potential here is huge and not recognised in the current share price, anyone selling must have missed the obvious. I've bought some more.
Ixico share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161023 12:04:09